Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

Unicycive Therapeutics (Nasdaq: UNCY) announced that CEO Shalabh Gupta, M.D., will present at the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026 at 3:45 p.m. ET.

Rhea-AI Summary

Unicycive Therapeutics (Nasdaq: UNCY) announced that CEO Shalabh Gupta, M.D., will present at the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026 at 3:45 p.m. ET. A live and archived webcast will be available via the company Investor Events and Presentations page.

Argus Apr 9 session

+3.10% close to close Open Argus

Details

News Market Reaction – UNCY

In the Apr 9 session, UNCY gained 3.10%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights continued investor-relations outreach as Unicycive’s CEO presents at a ...

Analysis

This announcement highlights continued investor-relations outreach as Unicycive’s CEO presents at a major virtual healthcare conference on April 15, 2026 at 3:45 p.m. ET. In recent months, filings have emphasized OLC’s resubmitted NDA, a June 2026 PDUFA date, and cash runway into 2027. Investors may watch for any new commentary from this event on launch preparedness, commercialization strategy, and how conference messaging aligns with the regulatory and financial disclosures already on record.

Key Figures

Conference edition: 25th Annual Presentation date: April 15, 2026 Presentation time: 3:45 p.m. ET

Conference edition

25th Annual

Needham Virtual Healthcare Conference

Presentation date

April 15, 2026

Needham Virtual Healthcare Conference

Presentation time

3:45 p.m. ET

Needham Virtual Healthcare Conference

Historical Context

5 past events · Latest: Mar 30

5 events

1. Mar 30

   Earnings & update

   24h Move

   -4.4%

   Full-year 2025 results, NDA resubmission acceptance, cash runway into 2027.

2. Feb 04

   Investor conference

   24h Move

   -5.9%

   CEO fireside chat at Guggenheim biotech summit with webcast access.

3. Jan 29

   Regulatory update

   24h Move

   -5.0%

   FDA acceptance of OLC NDA resubmission with June 27, 2026 PDUFA date.

4. Dec 29

   NDA resubmission

   24h Move

   -2.3%

   Resubmission of OLC NDA, expecting new 1H 2026 PDUFA date guidance.

5. Nov 25

   Investor events

   24h Move

   +3.6%

   Participation in December 2025 investor conferences with webcast availability.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LOS ALTOS, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Executive Officer, will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026, at 3:45 p.m. ET.

A link to the live and archived webcast may be accessed on the Unicycive website under the Investors section: Events and Presentations.

About Unicycive Therapeutics

Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. For more information, please visit Unicycive.com and follow us on LinkedIn and X.

Investor Contact:

Kevin Gardner
LifeSci Advisors
kgardner@lifesciadvisors.com

Media Contact:

Layne Litsinger
Real Chemistry
llitsinger@realchemistry.com

SOURCE: Unicycive Therapeutics, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Unicycive (UNCY) present at the Needham Virtual Healthcare Conference?

Unicycive will present on April 15, 2026 at 3:45 p.m. ET. According to the company, CEO Shalabh Gupta, M.D., will deliver the presentation and the session will be available via live webcast and archived replay on the Investor Events page.

How can investors watch Unicycive (UNCY) presentation at the April 15, 2026 conference?

Investors can watch via a live webcast and archived replay on the company website. According to the company, the webcast link will be posted under the Investors section: Events and Presentations for on-demand access.

Who from Unicycive (UNCY) will speak at the 25th Annual Needham Virtual Healthcare Conference?

CEO Shalabh Gupta, M.D., will present at the conference on April 15, 2026. According to the company, he will represent Unicycive and discuss corporate developments during the scheduled webcast session.

What topics will Unicycive (UNCY) likely cover during the Needham Virtual Healthcare Conference presentation?

The presentation will focus on Unicycive's clinical-stage kidney disease programs and corporate update. According to the company, the CEO's session will cover recent clinical progress and strategic priorities via the webcast.

Where is the Unicycive (UNCY) conference webcast hosted and when will the archive be available?

The webcast is hosted on Unicycive's investor website under Events and Presentations, with an archived replay available after the live session. According to the company, both live and archived access will be provided online for investors.